Arizona Tribune - Boulevard

NYSE - LSE

BCE	0.26%	23.46	$
JRI	-0.4%	12.35	$
AZN	-1.12%	162.7	$
RYCEF	-1.22%	20.5	$
RELX	0.66%	36.54	$
GSK	1.08%	50.82	$
BP	-0.45%	42.15	$
CMSC	-0.09%	21.29	$
BCC	-0.03%	78.75	$
CMSD	0%	21.18	$
RIO	-1.43%	103.3	$
RBGPF	0.11%	70.77	$
VOD	1%	16.04	$
BTI	-0.27%	56.13	$
NGG	-0.1%	79.35	$

Featured

UN, Nepal warn of climate threat after deadly floods

Nepal's foreign minister and the UN climate chief on Saturday warned of the growing threat from global warming to the Himalayas, as rescuers race to find thousands missing after torrential flooding along the border with China.

Rescuers dig into tunnel as missing toll from Nepal, China flood nears 3,000

Rescuers in Nepal and China on Saturday battled to locate thousands of people missing days after a deadly, tsunami-like wall of water and debris swept through the Himalayan region, engulfing entire villages.

Last news

Menhaden Fisheries Coalition Applauds Louisiana Wildlife & Fisheries Commission for Balanced, Science-Based Buffer Zone Recommendations

BATON ROUGE, LA / ACCESS Newswire / November 6, 2025 / The Menhaden Fisheries Coalition applauds the Louisiana Wildlife and Fisheries Commission for voting today in favor of a balanced proposal to modify menhaden buffer zones along portions of the Louisiana coast. The vote reflects a careful, science-first approach: state officials studied the issue, listened to stakeholders, and brought forward a proposal that adds new protections and enlarges the total protected footprint, even as it makes targeted, common-sense adjustments where warranted. Paired with the fleet's standardized hose-end cage gear and ongoing collaboration with stakeholders, this is the right path to keep Louisiana's fisheries healthy and its coastal communities working.

President Trump's Decision on Medical Cannabis Will Define His Legacy: Science or Marijuana Policy Stagnation

After DOJ Concedes DEA's Courts Are Unconstitutional, MMJ BioPharma Cultivation's Fight for Patients Lands on President Trump's Desk

Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2025

SAN DIEGO, CALIFORNIA / ACCESS Newswire / November 6, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing inflammation to optimize health, today reported its financial results for the three and nine months ended September 30, 2025.

NHI Announces Fourth Quarter 2025 Dividend

MURFREESBORO, TN / ACCESS Newswire / November 6, 2025 / National Health Investors, Inc. (NYSE:NHI) announced today that it will pay its fourth quarter dividend of $0.92 per common share on January 30, 2026, to stockholders of record as of December 31, 2025.

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2025

Reports Net Revenues of $191.8 million for the Three Months Ended September 30, 2025GAAP net income of $17.4 million, or $0.37 per share, for the third quarterAdjusted non-GAAP net income of $44.7 million, or $0.93 per share, for the third quarterCompany to hold a conference call today at 2:00 p.m. Pacific Time

Protagonist Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Following the NDA submission for icotrokinra treatment of adults and adolescents with moderate to severe plaque psoriasis to the U.S. FDA in July, the European Medicines Agency (EMA) application was submitted in SeptemberRusfertide granted breakthrough designation for patients in Polycythemia Vera (PV) and the subject of four presentations including 52-week results of the VERIFY Phase 3 Study at ASH, the 67th Annual American Society of Hematology (ASH) meeting in DecemberFirst patient dosed in the Phase 1 trial of PN-881, a first-in-class oral IL-17 peptide antagonistIND-enabling studies progressing as planned with triple-GLP/GIP/GCG agonists PN-477sc and PN-477oOral hepcidin development candidate expected to be nominated by year endCash, cash equivalents and marketable securities of $678.8 million as of September 30, 2025, anticipated to provide cash runway through at least end of 2028

NHI Announces Third Quarter 2025 Results

MURFREESBORO, TN / ACCESS Newswire / November 6, 2025 / National Health Investors, Inc. (NYSE:NHI) announced today its results for the three and nine months ended September 30, 2025.

Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Düsseldorf

BOULDER, CO / ACCESS Newswire / November 6, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, oral and nasal care, dermatological conditions, podiatry, and animal health care, today announced that it will be exhibiting at MEDICA 2025 in Düsseldorf, Germany, November 17-20, 2025.

Where Is the Best Udon in NYC?

The best Udon in NYC is at Tensai.

Malaysian Court Rules in Favor of Pastor Raymond Koh's Family Eight Years After His Public Abduction

BARTLESVILLE, OK / ACCESS Newswire / November 6, 2025 / The Voice of the Martyrs (VOM) joins with Susanna (Liew) Koh and her family in thanking the Lord for a significant legal victory in Malaysia. After nearly nine years of uncertainty surrounding the forced disappearance of Pastor Raymond Koh, the Malaysian High Court has ruled that one or more police officials were involved in his abduction, acting "oppressively and arbitrarily" under orders and misusing their power.

Medical Care Technologies (OTC Pink:MDCE) Enters Final Phase of Testing for First Consumer App, With Beta Launch Slated for Q4 2025

MESA, ARIZONA / ACCESS Newswire / November 6, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE), led by CEO Marshall Perkins, is thrilled to announce that the company is entering the final phase of testing for its highly anticipated first consumer application. This marks a major milestone as the company gears up for a beta launch in Q4 2025.

SOHM Inc. Releases White Paper on ABBIE, a Cas9-Guided Integrase Enabling Stable Gene Integration and Creation of SKOV3-GYS1 Cell Line for Drug Discovery

CHINO HILLS, CALIFORNIA / ACCESS Newswire / November 6, 2025 / SOHM, Inc. (OTCID:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, a leader in Gene Editing and Cell Engineering is pleased to announced the release of a technical white paper describing ABBIE, a Cas9-guided integrase platform that enables donor-DNA integration without double-strand breaks or viral vectors. Using ABBIE, the team established SKOV3-GYS1, an ovarian cancer cell line with stable overexpression of glycogen synthase 1 (GYS1) to support drug-discovery applications focused on glycogen metabolism.

Aspire Biopharma Engages with Global Pharmaceutical Leaders at CPHI Frankfurt to Advance Partnership Discussions for its Sublingual High-Dose Aspirin

ESTERO, FL / ACCESS Newswire / November 6, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug delivery technology, today announced its successful participation in the CPHI Frankfurt trade show, the world's largest pharmaceutical event. The Company engaged in numerous strategic discussions with global pharmaceutical companies regarding technical collaboration and licensing opportunities for its lead product candidate, a novel sublingual high-dose aspirin.

Encouraging Results from a First-in-Human Phase 1 Clinical Trial of IAVI's Lassa Vaccine Candidate Published in New England Journal of Medicine

One dose elicits robust and long-lasting immune responses in healthy adults in the U.S. and LiberiaKey takeaways:IAVI's Lassa vaccine candidate rVSVΔG-LASV-GPC has an acceptable safety profile and elicits durable immune responses.Phase 1 data builds on promising preclinical results and supports the conduct of an ongoing Phase 2 clinical trial in West Africa.Findings are consistent with previous studies of a similarly constructed licensed Ebolavirus vaccine.

REMINDER: Initial Groundbreaking Results of Proof-of-Concept Study of Jaguar Health's Crofelemer for Treatment of Pediatric Intestinal Failure to be Presented November 8, 2025 at North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) Annual Meeting

Results of ongoing investigator-initiated proof-of-concept trial of crofelemer in United Arab Emirates (UAE) demonstrate disease progression modification and reduction of total parenteral support (PS) in pediatric intestinal failure patients ranging between 12% to 37%

Entero Subsidiary Grid AI Accelerates Expansion into Hyperscaler AI Data Center Market with Integration of LV Grid

Integration boosts Grid AI's deployment capacity as AI data-center power demand approaches 50 GW, growing by over 165% through 2030i

Labor Smart, Inc. (Kultura Brands) Retires 2.545 Billion Common Shares; Continues Progress Toward Full Preferred H Conversion and Clean Cap Table

JACKSON, WY / ACCESS Newswire / November 6, 2025 / Labor Smart, Inc. (OTCID:LTNC), doing business as Kultura Brands, Inc., today announced the official retirement of 2,545,539,256 (2.545 billion) common shares of its stock, as verified by Empire Stock Transfer through the company's Transaction Report. This latest verified retirement brings the company's total shares retired over the past three weeks to approximately 3.875 billion, marking a significant milestone in Kultura Brands' ongoing share reduction and capital structure reform initiative.

VSee Engages Philippine Health Leaders and Former VP Robredo in Southeast Asia expansion effort

VSee explores collaboration with Philippine Tuberculosis Society and former VP Leni Robredo to expand digital health innovation for Naga City starting with maternal health and primary care

Aptevo Therapeutics Reports 3Q25 Financial Results And Provides A Business Update

89% of evaluable mipletamig patients achieve remission in combination therapy for frontline AML across two trialsIntroduces first trispecific molecules, APVO451 and APVO452, advancing therapies designed to overcome immune suppression in certain solid tumorsBoth molecules leverage Aptevo's unique use of the CRIS-7-derived CD3 binding domain, associated with favorable safety outcomes in the clinic; CD3 T-cell engager portfolio expanded to fiveCompany raises $18.7 million in the third quarter, $4.1 million since quarter end, extends cash runway into 4Q26

Club Car Wash Kicks Off Grand Opening in Joplin, Missouri, With $3,500 Giveaway

Get MVP Washes for Just $1 - Proceeds Go to Bright Futures

Moderna Reports Third Quarter 2025 Financial Results and Provides Business Updates

Reports third quarter revenue of $1.0 billion, GAAP net loss of $(0.2) billion and GAAP EPS of $(0.51)Narrows 2025 projected revenue range to $1.6 - $2.0 billionImproves 2025 expected GAAP operating expenses by $0.7 billion to a range of $5.2 - $5.4 billionIncreases 2025 expected year-end cash balance by $0.5 billion - $1 billion to a range of $6.5 - $7.0 billion

Zomedica Achieves ISO 13485 Certification, Underscoring Strengthened Quality Infrastructure and Commercial Potential

Certification enhances global market readiness, reinforces quality systems, and supports Zomedica's long-term growth strategy

SlicedHealth Elevates Hospital Contract Intelligence with SlicedIQ

New HIPPA-Compliant AI technology for Contract Modeling and Variance Analysis to Revolutionize Hospital Revenue Cycle Optimization

Diageo PLC Issues Fiscal 26 Q1 Trading Statement

LONDON, UK / ACCESS Newswire / November 6, 2025 / Flat Q1 organic net sales growth with volume +2.9%. Organic net sales growth across Europe, LAC and Africa offset by weakness in Chinese white spirits and a softer US consumer environment. Sharpening our strategy well advanced, and moving at pace to accelerate growth.

Promotions lift McDonald's sales in tricky consumer market

Fast-food giant McDonald's scored solid sales growth Wednesday following promotions to attract struggling consumers, with company shares rising despite profits missing expectations.

Mexico's Sheinbaum steps up cartel fight after murder of anti-narco mayor

The cold-blooded murder of a crusading Mexican mayor, who hunted drug traffickers from a helicopter, has put pressure on President Claudia Sheinbaum to step up her fight against the country's notorious cartels.

'Hostage diplomacy': longstanding Iran tactic presenting dilemma for West

Iran since the Islamic revolution has employed the tactic of arresting Westerners in a bid to extract concessions from its foes, in a strategy of "hostage diplomacy" that has long presented Europe and the United States with a dilemma, observers say.

At least 9 dead after cargo plane crashes near Louisville airport

The death toll from a UPS cargo plane crashing in Louisville has risen to nine with more fatalities feared, Kentucky's governor said Wednesday, as search efforts continued and the airport resumed flights.

French pair released by Iran await return home

A French pair released by Iran after over three years in prison on espionage charges their families vehemently denied were on Wednesday awaiting permission to be allowed to return to France and end their ordeal.

Champagne and cheers across New York as Mamdani soars to victory

Donald Trump had decisively won the US presidential election last November and very few people outside New York's leftist circles knew Zohran Mamdani, who had just declared his longshot mayoral candidacy.

Beyond limits: Croatian freediver's breathtaking record

For almost 30 minutes, Vitomir Maricic didn't take a breath. Face down in a pool, surrounded by anxious onlookers, the Croatian freediver fought spasming pain to redefine what doctors thought was possible.

Tottenham supporting Udogie after alleged gun threat in London

Tottenham say they are supporting 22-year-old Italian international defender Destiny Udogie and his family after he was allegedly threatened with a gun in London.

Arizona Tribune - Boulevard (English)